Digital Humanity as a Feature, Not a Bug: Insights from Frontiers He... YourCoach Health’s Eugene and Marina Borukhovich spoke with pharmaphorum after their Frontiers Health session.
News FDA clears Sanofi's Type 3 Gaucher therapy Infilbray Sanofi's Infilbray has become the first drug to treat neurological symptoms of rare lysosomal storage disorder Type 3 Gaucher disease (GD3) in the US.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.